Upexi Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Allan Marshall

Amministratore delegato

US$1.3m

Compenso totale

Percentuale dello stipendio del CEO	66.1%
Mandato del CEO	5.5yrs
Proprietà del CEO	14.1%
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	3.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Allan Marshall rispetto agli utili di Upexi?
Data	Compenso totale	Stipendio	Guadagni aziendali
Mar 31 2024	n/a	n/a	-US$23m
Dec 31 2023	n/a	n/a	-US$20m
Sep 30 2023	n/a	n/a	-US$14m
Jun 30 2023	US$1m	US$840k	-US$15m
Mar 31 2023	n/a	n/a	-US$2m
Dec 31 2022	n/a	n/a	-US$1m
Sep 30 2022	n/a	n/a	-US$7m
Jun 30 2022	US$5m	US$840k	-US$6m
Mar 31 2022	n/a	n/a	-US$923k
Dec 31 2021	n/a	n/a	US$244k
Sep 30 2021	n/a	n/a	US$3m
Jun 30 2021	US$1m	US$285k	US$3m
Mar 31 2021	n/a	n/a	-US$470k
Dec 31 2020	n/a	n/a	-US$3m
Sep 30 2020	n/a	n/a	-US$5m
Jun 30 2020	US$2m	US$300k	-US$5m

Compensazione vs Mercato: La retribuzione totale di Allan ($USD 1.27M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 471.55K ).

Compensazione vs guadagni: La retribuzione di Allan è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Allan Marshall (57 yo)

5.5yrs

Mandato

US$1,271,068

Compensazione

Mr. Allan J. Marshall is Chief Executive Officer at Upexi, Inc. (formerly known as Grove, Inc.) since May 2019 and has been its Director since May 17, 2019. Mr. Marshall joined the Company as Chief Executi...

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Allan Marshall	CEO, President & Chairman of the Board	5.5yrs	US$1.27m	14.07% € 796.1k
Andrew Norstrud	CFO & Director	4.8yrs	US$430.00k	1.46% € 82.7k
Eugene Salkind	Independent Director	3.8yrs	US$148.50k	11.72% € 662.8k
Thomas Williams	Independent Director	3.8yrs	US$148.50k	Nessun dato
Lawrence Dugan	Independent Director	3.8yrs	US$150.50k	0.13% € 7.5k

3.8yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 7TQ0 sono considerati esperti (durata media dell'incarico 3.8 anni).

Upexi Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Insufficient new directors

Upexi, Inc., Annual General Meeting, Jun 10, 2024

Insufficient new directors

Upexi, Inc., Annual General Meeting, Jun 26, 2023

CEO, President & Chairman of the Board recently bought €70k worth of stock

High number of new and inexperienced directors

Recent updates

Upexi Receives Notice from the Nasdaq Stock Market

Upexi, Inc. announced delayed 10-Q filing

Upexi, Inc. to Report Fiscal Year 2024 Results on Nov 01, 2024

Nasdaq Grants Additional 180 Days to Upexi to Regain Compliance with Minimum Bid Price Requirement

Upexi, Inc. announced delayed annual 10-K filing

Insufficient new directors

David Romano, Nick Romano and Eric Limont acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million.

E-Core Holdings, LLC acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million.

Upexi Provides Update on Filing Form 10Q for March 31, 2024

Upexi, Inc. to Report Q3, 2024 Results on Jun 24, 2024

MFA Holdings Corp., 1000915944 Ontario Inc and Nutraproducts LLC acquired VitaMedica Corporation from Upexi, Inc. (NasdaqCM:UPXI) for $6 million.

Upexi, Inc. announced delayed 10-Q filing

Upexi, Inc., Annual General Meeting, Jun 10, 2024

New major risk - Market cap size

Upexi Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Under Nasdaq Listing Rule 5550(a)(2)

Second quarter 2024 earnings released: US$0.12 loss per share (vs US$0.17 profit in 2Q 2023)

Insufficient new directors

Upexi, Inc. Revises Preliminary and Unaudited Financial Guidance for the First Quarter Ended September 30, 2023

Upexi, Inc. Pet Care Brand, Luckytail, Announces Expansion of Product Line to Include All-Natural Dog Supplements

Amplifyir Inc. acquired 100% stake in Interactive Offers LLC from Upexi, Inc. (NasdaqCM:UPXI) for $1.25 million.

New major risk - Share price stability

Upexi, Inc., Annual General Meeting, Jun 26, 2023

Third quarter 2023 earnings released: US$0.11 loss per share (vs US$0.003 loss in 3Q 2022)

Upexi, Inc. announced delayed 10-Q filing

Second quarter 2023 earnings released: EPS: US$0.17 (vs US$0.004 in 2Q 2022)

CEO, President & Chairman of the Board recently bought €70k worth of stock

First quarter 2023 earnings released: US$0.15 loss per share (vs US$0.033 profit in 1Q 2022)

High number of new and inexperienced directors

Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of E-Core, Inc.

Bloomios, Inc. (OTCPK:BLMS) acquired Infusionz, LLC from Upexi, Inc. (NasdaqCM:UPXI) for $23.5 million.

Upexi, Inc. Files Patent for its Single Click-to-optin Technology

Upexi, Inc. Provides Revenue Guidance for the Fiscal Year 2023

Full year 2022 earnings released: US$0.13 loss per share (vs US$0.25 profit in FY 2021)

Upexi, Inc. Appoints Anthony Bazan as Chief Operating Officer

Investor sentiment deteriorated over the past week

Grove, Inc. (NasdaqCM:GRVI) signed a non-binding LOI to acquire E-Core, Inc.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Grove, Inc.(NasdaqCM:GRVI) dropped from Russell Microcap Value Index

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Grove, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings released: US$0.003 loss per share (vs US$0.071 profit in 3Q 2021)

High number of new and inexperienced directors

Grove, Inc. (NasdaqCM:GRVI) acquired Cygnet Online LLC.

Grove, Inc., Annual General Meeting, May 24, 2022

Investor sentiment improved over the past week

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS US$0.033 (vs US$0.078 loss in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$0.25 (vs US$0.53 loss in FY 2020)

Grove, Inc. (NasdaqCM:GRVI) signed a letter of intent to acquire Interactive Offers LLC.

Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of VitaMedica Corporation.

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Membri del Consiglio di amministrazione

Durata media

Età media